Assigned Patents. Assigned Patents" means only those
Assigned Patents. Subject to Sections 2.2 and 2.3 below, Adaptec hereby grants, conveys and assigns (and agrees to cause its appropriate Subsidiaries to grant, convey and assign) to Roxio, by execution hereof (or, where appropriate or required, by execution of separate instruments of assignment), all its (and their) right, title and interest in and to the Assigned Patents, to be held and enjoyed by Roxio, its successors and assigns. Adaptec further grants, conveys and assigns (and agrees to cause its appropriate Subsidiaries to grant, convey and assign) to Roxio all its (and their) right, title and interest in and to any and all causes of action and rights of recovery for past infringement of the Assigned Patents and the right to claim priority from the Assigned Patents. Adaptec will, without demanding any further consideration therefor, at the request and expense of Roxio (except for the value of the time of Adaptec employees), do (and cause its Subsidiaries to do) all lawful and just acts, that may be or become necessary for prosecuting, sustaining, obtaining continuations, continuations-in-part and divisionals of, or reissuing or re-examining, said Assigned Patents and for evidencing, maintaining, recording and perfecting Roxio's rights to said Assigned Patents, including but not limited to execution and acknowledgement of (and causing its Subsidiaries to execute and acknowledge) assignments and other instruments in a form reasonably required by Roxio for each Patent jurisdiction.
Assigned Patents. Sellers’ representations, warranties and disclosures set forth in this Section 3.2 and Section 3.3 (to the extent Section 3.3 deals with the Assigned Patents) shall not apply to any fact, circumstance or matter arising prior to the period before July 29, 2011 (the “Ownership Date”) even if such fact, circumstance or matter continued or continues after the Ownership Date (the 10 “Nortel Exception”); provided that Sellers’ representations and warranties shall be to Sellers’ Knowledge (even prior to the Ownership Date) where Sellers’ Knowledge is indicated in this Section 3.2. Sellers’ representations, warranties and disclosures set forth in this Section 3.2 and Section 3.3 (to the extent Section 3.3 deals with the Assigned Patents) shall not apply to any Jointly Owned Patent(s) to the extent that such representations, warranties and/or disclosures are inaccurate or incorrect as a result of any failure to obtain any consent or waiver required for the assignment thereof, whether at Law or pursuant to any Existing Encumbrance, including, without limitation, any joint ownership agreement.
(a) Except as set forth in Schedule 3.2(a), Sellers have legal, good and marketable title to all patents and pending applications identified on Schedule 1 to A attached hereto and the Assigned Patents. The list of patents and patent applications set forth on Schedule 1 of the Patent Assignment Agreement is a complete and accurate list of all of the patents and patent applications owned by any of the Sellers as of the date hereof. Sellers have all requisite power and authority (which in each case is not subject to revocation or withdrawal of approval by any partner or member of any of the Sellers) to assign all of such patents and pending applications and the Assigned Patents in accordance with the terms of this Agreement. Sellers shall be entitled to update Schedule 1 prior to the Closing to reflect changes in the status of patents (without removal of such patents) that have expired or have been issued between the Agreement Date and the Closing and the patents and patent applications that have been filed between the Agreement Date and Closing or have been abandoned in accordance with Section 5.8(a) between the Agreement Date and Closing, and for changes in filing or serial numbers (such as may occur in transitioning to the national phase for PCT applications or as may occur when transitioning to the national phase for European patents or patent applications) and/or to correct c...
Assigned Patents. Del Mar shall, at its own expense and at its discretion, file, maintain, prosecute and defend all Assigned Patents. At the request of Del Mar, Valent shall provide reasonable cooperation in connection with such filing, prosecution, maintenance or defense. Del Mar shall reimburse Valent for any reasonable out-of-pocket expenses or costs incurred in connection with such cooperation.
Assigned Patents. Assigned Patents" shall mean and ---------------- include all patents set forth on Exhibit A attached hereto and any and all continuations, divisional and continuation-in-part applications based thereon, and all patents issuing thereon, including reissues, patents of addition and extensions thereof.
Assigned Patents. The 675 Patent and/or the 787 Patent, as the case may be.
Assigned Patents. The Assigned Patents, subject to the terms and conditions of this Agreement, are those assocated with the following Agilent patent families: 190579 10010745 10020825 10030979 10040644 190596 10010816 10020851 10030985 10040670 191257 10010835 10020880 10031023 10040678 191528 10010869 10020917 10031048 10040679 191610 10010880 10020981 10031075 10040748 490051 10010980 10021061 10031166 10040886 10001804 10011095 10021089 10031220 10040907 10001940 10011122 10021092 10031229 10040927 10002352 10011125 10021116 10031230 10040959 10003329 10011162 10021119 10031276 10041015 10003336 10011201 10021216 10031298 10041025 10003342 10011219 10021250 10031301 10041043 10003845 10011298 10030041 10031355 10041057 10003879 10011300 10030042 10031555 10041086 10003880 10011302 10030056 10031556 10041127 10003976 10011338 10030059 10031564 10041143 10004017 10011355 10030061 10040010 10041158 10004048 10011387 10030094 10040025 10041159 10004095 10020043 10030114 10040032 10041239 10004195 10020076 10030186 10040033 10041240 10004221 10020111 10030268 10040054 10041242 10004222 10020154 10030335 10040055 10041244 10004384 10020205 10030362 10040070 10041248 10004402 10020206 10030379 10040101 10041249 10010023 10020245 10030469 10040152 10041253 10010274 10020417 10030610 10040292 10041315 10010323 10020454 10030611 10040321 10041316 10010334 10020524 10030612 10040352 10041325 10010400 10020532 10030724 10040476 10041328 10010403 10020610 10030762 10040481 10041329 10010493 10020611 10030838 10040492 10041333 10010657 10020693 10030919 10040569 10041382 10010689 10020725 10030972 10040580 10041390 10041504 10051506 10060349 10070124 1093738 10041556 10051635 10060353 10070146 1093804 10041568 10051689 10060354 10070147 1093811 10041598 10051691 10060356 10070162 1093854 10041666 10051694 10060358 10070176 1094280 10041675 10051738 10060360 10070192 1094336 10041676 10051739 10060365 10070194 1094401 10050020 10051740 10060366 10070219 1094470 10050034 10051743 10060368 10070220 1094576 10050041 10060031 10060374 10070239 1094643 10050124 10060044 10060412 10070251 1094669 10050125 10060051 10060426 10070262 1094725 10050132 10060059 10060448 10070265 1094750 10050137 10060075 10060449 10070276 1094752 10050156 10060101 10060459 10070290 1094769 10050196 10060122 10060463 10070292 1094855 10050203 10060135 10060491 10070328 1094862 10050204 10060138 10060493 10070329 1094892 10050214 10060146 10060501 10070330 1094956 10050216 10060157 10060521 10070331 1094957 100503...
Assigned Patents. “Assigned Patents” means all Patents identified in Schedule C, attached hereto as part of this IPAL Agreement, including any Foreign Counterparts.
Assigned Patents. Patent # Title
